Company news

ProKidney Corp. news in 2025

ProKidney Corp.'s news releases, calls and decks from 2025, newest first.

View company

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

November 9, 2025

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

November 5, 2025

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

October 28, 2025

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025

October 19, 2025

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

August 26, 2025

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

August 11, 2025

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

July 14, 2025

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

July 8, 2025

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

July 7, 2025

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

June 30, 2025

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

May 11, 2025

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

March 16, 2025

ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 6, 2025

Decks in 2025